Summit Therapeutics’ Chief Accountant Exercises New Stock‑Option Grant Amid Growing Insider Buying Surge【SMTN】
Insider alert: Summit Therapeutics’ chief accountant Anand Bhaskar just exercised a 30,000‑share option, signaling confidence in the company’s antibiotic pipeline and a bullish insider trend that may boost stock value.
3 minutes to read